Nutrients · 2021 · 42 citations · 33 references
AgricultureNutritionNutritional SciencesClinical NutritionHuman NutritionPediatric NutritionDepressive DisordersEssential Fatty AcidsVitamin DVitamin SupplementationChildhood Depressive DisordersFatty AcidsFish Oil SupplementationOmega-3 Fatty Acid EmulsionsOmega-3 Fatty Acid MetabolismOmega-3 Fatty AcidsOmega-6 Fatty AcidsOmega-6 To Omega-3 Ratio
In the DEPOXIN project, we have found that a high ratio of omega-6/omega-3 fatty acids (FA) is associated with worsening of depressive symptoms in children and adolescents with depressive disorder (DD) and that the 12-week omega-3 FA supplementation modulates DD symptoms. Here we present our results of the secondary outcomes: the levels of thromboxane (TXB), brain-derived neurotrophic factor (BDNF), homocysteine (HCy) and vitamin D. Fifty-eight patients were randomized into two arms. One group received a fish oil emulsion enriched with omega-3 FA, and the other received a sunflower oil emulsion containing omega-6 FA, for 12 weeks. Depressive symptoms were evaluated, using the Child’s Depressive Inventory (CDI). The patients with DD had elevated TXB levels and decreased vitamin D levels, as compared to healthy controls. Both CDI and omega-6/omega-3 ratio correlated positively with TXB and negatively with BDNF at baseline. Compared to the omega-6 FA group, the supplementation with omega-3 FA for 12 weeks significantly reduced plasma TXB (p = 0.024) and increased BDNF (p = 0.011) levels. No changes in HCy and vitamin D were observed. Our results demonstrate the possible role of TXB and BDNF in the pathophysiology of DD and the benefits of omega-3 FA supplementation. The study was registered with the ISRCTN registry (ISRCTN81655012).
33
The role of eicosanoids in the brain.
Daniella Tassoni, Gunveen Kaur, Richard S. Weisinger et al. · PubMed · 2008 · 186 citations